Your browser doesn't support javascript.
loading
Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada.
Skowronski, Danuta M; Setayeshgar, Solmaz; Zou, Macy; Prystajecky, Natalie; Tyson, John R; Galanis, Eleni; Naus, Monika; Patrick, David M; Sbihi, Hind; El Adam, Shiraz; Henry, Bonnie; Hoang, Linda M N; Sadarangani, Manish; Jassem, Agatha N; Krajden, Mel.
Afiliación
  • Skowronski DM; BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada.
  • Setayeshgar S; University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada.
  • Zou M; BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada.
  • Prystajecky N; BC Centre for Disease Control, Data and Analytics Services, Vancouver, British Columbia, Canada.
  • Tyson JR; BC Centre for Disease Control, Public Health Laboratory, Vancouver, British Columbia, Canada.
  • Galanis E; University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, British Columbia, Canada.
  • Naus M; BC Centre for Disease Control, Public Health Laboratory, Vancouver, British Columbia, Canada.
  • Patrick DM; University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, British Columbia, Canada.
  • Sbihi H; BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada.
  • El Adam S; University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada.
  • Henry B; BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada.
  • Hoang LMN; University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada.
  • Sadarangani M; BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada.
  • Jassem AN; University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada.
  • Krajden M; University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada.
Clin Infect Dis ; 74(7): 1158-1165, 2022 04 09.
Article en En | MEDLINE | ID: mdl-34244723
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Canadá